Cargando…
Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States
The Advisory Committee on Immunization Practices (ACIP) recommended phased allocation of SARS-CoV-2 vaccines in December 2020. To support the development of this guidance, we used a mathematical model of SARS-CoV-2 transmission to evaluate the relative impact of three vaccine allocation strategies o...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Science
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818403/ https://www.ncbi.nlm.nih.gov/pubmed/35260267 http://dx.doi.org/10.1016/j.vaccine.2022.02.015 |
_version_ | 1784645820998483968 |
---|---|
author | Walker, Joseph Paul, Prabasaj Dooling, Kathleen Oliver, Sara Prasad, Pragati Steele, Molly Gastañaduy, Paul A. Johansson, Michael A. Biggerstaff, Matthew Slayton, Rachel B. |
author_facet | Walker, Joseph Paul, Prabasaj Dooling, Kathleen Oliver, Sara Prasad, Pragati Steele, Molly Gastañaduy, Paul A. Johansson, Michael A. Biggerstaff, Matthew Slayton, Rachel B. |
author_sort | Walker, Joseph |
collection | PubMed |
description | The Advisory Committee on Immunization Practices (ACIP) recommended phased allocation of SARS-CoV-2 vaccines in December 2020. To support the development of this guidance, we used a mathematical model of SARS-CoV-2 transmission to evaluate the relative impact of three vaccine allocation strategies on infections, hospitalizations, and deaths. All three strategies initially prioritized healthcare personnel (HCP) for vaccination. Strategies of subsequently prioritizing adults aged ≥65 years, or a combination of essential workers and adults aged ≥75 years, prevented the most deaths. Meanwhile, prioritizing adults with high-risk medical conditions immediately after HCP prevented the most infections. All three strategies prevented a similar fraction of hospitalizations. While no model is capable of fully capturing the complex social dynamics which shape epidemics, exercises such as this one can be a useful way for policy makers to formalize their assumptions and explore the key features of a problem before making decisions. |
format | Online Article Text |
id | pubmed-8818403 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier Science |
record_format | MEDLINE/PubMed |
spelling | pubmed-88184032022-02-07 Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States Walker, Joseph Paul, Prabasaj Dooling, Kathleen Oliver, Sara Prasad, Pragati Steele, Molly Gastañaduy, Paul A. Johansson, Michael A. Biggerstaff, Matthew Slayton, Rachel B. Vaccine Short Communication The Advisory Committee on Immunization Practices (ACIP) recommended phased allocation of SARS-CoV-2 vaccines in December 2020. To support the development of this guidance, we used a mathematical model of SARS-CoV-2 transmission to evaluate the relative impact of three vaccine allocation strategies on infections, hospitalizations, and deaths. All three strategies initially prioritized healthcare personnel (HCP) for vaccination. Strategies of subsequently prioritizing adults aged ≥65 years, or a combination of essential workers and adults aged ≥75 years, prevented the most deaths. Meanwhile, prioritizing adults with high-risk medical conditions immediately after HCP prevented the most infections. All three strategies prevented a similar fraction of hospitalizations. While no model is capable of fully capturing the complex social dynamics which shape epidemics, exercises such as this one can be a useful way for policy makers to formalize their assumptions and explore the key features of a problem before making decisions. Elsevier Science 2022-03-25 2022-02-07 /pmc/articles/PMC8818403/ /pubmed/35260267 http://dx.doi.org/10.1016/j.vaccine.2022.02.015 Text en Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Walker, Joseph Paul, Prabasaj Dooling, Kathleen Oliver, Sara Prasad, Pragati Steele, Molly Gastañaduy, Paul A. Johansson, Michael A. Biggerstaff, Matthew Slayton, Rachel B. Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States |
title | Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States |
title_full | Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States |
title_fullStr | Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States |
title_full_unstemmed | Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States |
title_short | Modeling strategies for the allocation of SARS-CoV-2 vaccines in the United States |
title_sort | modeling strategies for the allocation of sars-cov-2 vaccines in the united states |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8818403/ https://www.ncbi.nlm.nih.gov/pubmed/35260267 http://dx.doi.org/10.1016/j.vaccine.2022.02.015 |
work_keys_str_mv | AT walkerjoseph modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT paulprabasaj modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT doolingkathleen modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT oliversara modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT prasadpragati modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT steelemolly modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT gastanaduypaula modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT johanssonmichaela modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT biggerstaffmatthew modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates AT slaytonrachelb modelingstrategiesfortheallocationofsarscov2vaccinesintheunitedstates |